Pet Diabetes Care Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The pet diabetes care market addresses the growing prevalence of diabetes mellitus in companion animals, with dogs and cats representing the primary patient population. Products span insulin formulations and delivery devices, point-of-care diagnostic systems, continuous glucose monitoring tools, and prescription therapeutic diets formulated to manage glycemic response.

• •Market valued at approximately $2.33 billion in 2025 with a compound annual growth rate of 8.36%
• •Estimated canine diabetes prevalence ranges from 1 in 100 to 1 in 500 dogs; feline diabetes affects roughly 1 in 230 cats
• •The market covers both therapeutic products and diagnostic/monitoring devices sold through veterinary clinics, specialty pharmacies, and e-commerce channels

Rising companion animal obesity rates, linked to sedentary lifestyles and overfeeding, are a primary factor behind increased diabetes incidence in pets. Greater veterinary education around recognizing and treating diabetes has improved diagnosis rates, while advances in animal insulin formulations and delivery systems have made management more effective.

• •Humanization of pets has led owners to invest more heavily in specialized veterinary care and premium health products
• •Expansion of pet insurance coverage has reduced out-of-pocket costs for owners, encouraging proactive diabetes management
• •Growing numbers of board-certified veterinary endocrinologists have elevated treatment standards globally

The market is commonly segmented by animal type, product category, and distribution channel, with dogs accounting for a slightly larger share due to higher diagnosis volumes. North America holds the largest market share, supported by high pet ownership, advanced veterinary infrastructure, and widespread pet insurance adoption.

• •Europe represents the second-largest regional market, driven by strong veterinary regulatory frameworks and increasing companion animal healthcare spending
• •Asia-Pacific is projected as the fastest-growing region, with rising middle-class pet ownership and expanding veterinary service networks
• •Key product segments include insulin and insulin analogs, glucose monitoring devices, urine test strips, and prescription therapeutic diets

What are the recent trends and outlook?

The market is expected to continue its steady expansion, supported by product innovation and growing consumer willingness to invest in long-term pet health management. Integration of digital health tools, including smart feeders, connected glucose monitors, and telemedicine platforms, is beginning to reshape how pet diabetes is monitored and managed.

• •Continuous glucose monitoring systems designed for companion animals are gaining traction among veterinary specialists
• •Therapeutic diet formulations with precise glycemic indices are becoming a standard part of multi-modal diabetes management protocols
• •Advancements in telemedicine and remote monitoring are expected to improve owner compliance and enable earlier detection of glucose irregularities